These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 24816643

  • 1. Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion.
    Peña JR, Saidman SL, Girouard TC, Meister E, Dzik WH, Makar RS.
    Am J Hematol; 2014 Sep; 89(9):E133-7. PubMed ID: 24816643
    [Abstract] [Full Text] [Related]

  • 2. Routine Solid Phase Multiplex Anti-HLA Antibody Tests Predict Platelet Refractoriness.
    Peña JRA, Makar RS.
    Am J Clin Pathol; 2019 Jul 05; 152(2):146-154. PubMed ID: 31065667
    [Abstract] [Full Text] [Related]

  • 3. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A, Pavenski K.
    Transfus Med Rev; 2020 Oct 05; 34(4):250-257. PubMed ID: 33127210
    [Abstract] [Full Text] [Related]

  • 4. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S.
    Transfus Med; 2018 Feb 05; 28(1):40-46. PubMed ID: 28516675
    [Abstract] [Full Text] [Related]

  • 5. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC.
    J Surg Res; 2020 Nov 05; 255():99-105. PubMed ID: 32543385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Platelet transfusion refractoriness.
    Hod E, Schwartz J.
    Br J Haematol; 2008 Jul 05; 142(3):348-60. PubMed ID: 18510692
    [Abstract] [Full Text] [Related]

  • 11. Platelet transfusion refractoriness and anti-HLA immunization.
    Blandin L, Dougé A, Fayard A, Bay JO, Berlie G, Pereira B, Lemal R, Rouzaire P.
    Transfusion; 2021 Jun 05; 61(6):1700-1704. PubMed ID: 33709433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L, Woodfield DG.
    N Z Med J; 1984 Oct 24; 97(766):719-21. PubMed ID: 6595558
    [Abstract] [Full Text] [Related]

  • 15. Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets.
    Heuer L, Blumenberg D.
    Blood Coagul Fibrinolysis; 2005 Jun 24; 16(4):287-90. PubMed ID: 15870549
    [Abstract] [Full Text] [Related]

  • 16. The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients.
    Matsuhashi M, Tsuno NH, Sone S, Mishima Y, Nagura Y, Watanabe-Okochi N, Ikeda T, Kashiwase K, Fukuda S, Iriyama T, Hyodo H, Yamashita T, Kamei Y, Arai S, Minami M, Fujii T, Kurokawa M, Tozuka M, Takahashi K, Santoso S.
    Transfusion; 2014 Apr 24; 54(4):1093-9. PubMed ID: 24147542
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y.
    Nihon Rinsho; 1997 Sep 24; 55(9):2392-8. PubMed ID: 9301306
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.